Skip to search formSkip to main contentSkip to account menu

DAT regimen

Known as: Daunorubicin-AraC-Thioguanine Regimen, Daunorubicin-Cytarabine-Thioguanine Regimen, MRC AML10 Study-DAT Regimen 
A regimen consisting of daunorubicin, cytarabine (Ara-C) and thioguanine, used as an induction treatment for childhood acute myeloid leukemia (AML).
National Institutes of Health

Related topics

Related topics

5 relations
CytarabineDaunorubicinTAD regimenThioguanine
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
University of Twente
This thesis deals with the problem of seam detection for robotic laser welding applications. Within the Mechanical Automation… 
2016
2016
Increased Expression of EGR-1 in Diabetic Human Adipose Tissue-Derived Mesenchymal Stem Cells Reduces Their Wound Healing Capacity.
The prevalence of type 2 diabetes mellitus (T2DM), which leads to diabetic complications, has been increasing worldwide. The… 
Highly Cited
2014
Highly Cited
2014
Reduced Dopamine Transporter Functioning Induces High-Reward Risk-Preference Consistent with Bipolar Disorder
Individuals with bipolar disorder (BD) exhibit deleterious decision making, negatively impacting their lives. Such aberrant… 
2013
2013
Characterization of direct antiglobulin test‐negative autoimmune hemolytic anemia: A study of 154 cases
Direct antiglobulin test (DAT)‐negative (DAT‐)autoimmune hemolytic anemia (AIHA) is empirically thought to show the same clinical… 
2012
2012
Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram
Social anxiety disorder (SAD) is characterised by fear of social or performance situations where the individual is exposed to… 
Highly Cited
2011
Highly Cited
2011
Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania
Reduced functioning of the dopamine transporter (DAT) has been linked to bipolar disorder (BD). Mice with reduced DAT functioning… 
Highly Cited
1990
Highly Cited
1990
MACA-a New Channel Access Method for Packet Radio
n a The existing Carrier Sense Multiple Access (CSMA) method widely used i mateur packet radio on shared simplex packet radio… 
1988
1988
Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia.
Thirty-five patients with acute myelogenous leukemia were treated with aclacinomycin A (60 mg/m2/day for 5 days) and VP-16-213… 
Highly Cited
1986
Highly Cited
1986
Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia.
One patient with acute nonlymphocytic leukemia (ANLL) in remission was given intensive chemotherapy (DAT regimen) as late… 
1980
1980
Blast cell kinetics and prognosis in acute nonlymphocytic leukemia.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License